PTK2 and nonpapillary renal cell carcinoma: Our study revealed the intracellular function of APOL1 as a tumor suppressor in renal cancer cell EMT and metastasis through FAK/Akt/GSK3β and NFκB, which may be potentially targeted to control ccRCC metastasis (Figure 5).